US Stock MarketDetailed Quotes

WGS GeneDx Holdings

Watchlist
  • 78.710
  • +6.640+9.21%
Close Nov 22 16:00 ET
  • 78.740
  • +0.030+0.04%
Post 20:01 ET
2.16BMarket Cap-25472P/E (TTM)

GeneDx Holdings Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

GeneDx Holdings Q3 2024 Earnings Date

Currency：USDOct 29, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
64.99M
76.87M
+11.89M
Beat Est.
+21.92%
+44.22%
+18.29%
EPS
-0.44
-0.31
+0.13
Beat Est.
+73.18%
+81.10%
+29.53%
Analyst Rating
Strong Buy

Oct 31, 2024

GeneDx Holdings Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 77.799M--
--2024/Q4-- / 80.224M--
Oct 29, 20242024/Q376.874M / 64.988M--
Jul 30, 20242024/Q270.514M / 59.311M--
Apr 29, 20242024/Q162.422M / 49.453M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 77.799M--
--2024/Q4-- / 80.224M--
Oct 29, 20242024/Q376.874M / 64.988M--
Jul 30, 20242024/Q270.514M / 59.311M--
Apr 29, 20242024/Q162.422M / 49.453M--

Unlock Free Earnings Estimates

GeneDx Holdings Earnings Reports

  • 10-Q: Q3 2024 Earnings Report

    Oct 29 08:23 ET

  • 8-K: GeneDx Reports Third Quarter 2024 Financial Results and Business Highlights

    Oct 29 08:13 ET

  • 10-Q: Q2 2024 Earnings Report

    Jul 30 16:24 ET

  • 8-K: GeneDx Reports Second Quarter 2024 Financial Results and Business Highlights

    Jul 30 16:18 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 31, 2024

    Strong Buy

    • Buy

      75.00%

    • Hold

      25.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data